UNITED THERAPEUTICS CORP (UTHR) Forecast, Price Target & Analyst Ratings

NASDAQ:UTHR • US91307C1027

Current stock price

588.38 USD
+7.87 (+1.36%)
At close:
588.38 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNITED THERAPEUTICS CORP (UTHR).

Forecast Snapshot

Consensus Price Target

Price Target
$627.88
+ 6.71% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$6.96
Revenue Estimate
816.92M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.90%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$627.88
Upside
+ 6.71%
From current price of $588.38 to mean target of $627.88, Based on 21 analyst forecasts
Low
$475.71
Median
$637.50
High
$769.65

Price Target Revisions

1 Month
14.83%
3 Months
16.33%

Price Target Summary

21 Wall Street analysts provided a forecast for the next 12 months for UTHR. The average price target is 627.88 USD. This implies a price increase of 6.71% is expected in the next year compared to the current price of 588.38.
The average price target has been revised upward by 16.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

UTHR Current Analyst RatingUTHR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

UTHR Historical Analyst RatingsUTHR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
81.90%
UTHR was analyzed by 21 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about UTHR.
In the previous month the buy percentage consensus was at a similar level.
UTHR was analyzed by 21 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-03-31Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-03-31B of A SecuritiesMaintains Neutral -> Neutral
2026-03-31HC Wainwright & Co.Maintains Buy -> Buy
2026-03-30TD CowenMaintains Buy -> Buy
2026-03-23Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-03-12Cantor FitzgeraldMaintains Overweight -> Overweight
2026-03-05UBSMaintains Buy -> Buy
2026-02-26TD CowenMaintains Buy -> Buy
2026-02-26OppenheimerMaintains Outperform -> Outperform
2026-02-26RBC CapitalMaintains Outperform -> Outperform
2026-02-26Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-02-26HC Wainwright & Co.Maintains Buy -> Buy
2026-01-06UBSMaintains Buy -> Buy
2025-11-06UBSMaintains Buy -> Buy
2025-10-30RBC CapitalMaintains Outperform -> Outperform
2025-10-30Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-10-30HC Wainwright & Co.Maintains Buy -> Buy
2025-10-10Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-09-29UBSMaintains Buy -> Buy
2025-09-26RBC CapitalInitiate Outperform
2025-09-10Cantor FitzgeraldMaintains Overweight -> Overweight
2025-09-05OppenheimerMaintains Outperform -> Outperform
2025-09-05HC Wainwright & Co.Maintains Buy -> Buy
2025-09-04UBSMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$6.96
Revenue Estimate
816.92M
Revenue Q2Q
2.83%
EPS Q2Q
5.05%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-1.07%
Revenue (3 Months)
-2.37%
EPS (1 Month)
-1.76%
EPS (3 Months)
-5.53%

Next Earnings Summary

UTHR is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 6.96 USD and the consensus revenue estimate is 816.92M USD.
The next earnings revenue estimate has been revised downward by 2.37% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
UTHR revenue by date.UTHR revenue by date.
2.328B
20.20%		2.877B
23.63%		3.183B
10.61%		3.386B
6.39%		3.866B
14.18%		4.474B
15.73%		5.069B
13.30%		5.657B
11.60%		6.505B
14.99%		6.848B
5.27%		7.253B
5.91%
EBITDA
YoY % growth
UTHR ebitda by date.UTHR ebitda by date.
1.242B
19.14%		1.521B
22.46%		1.603B
5.41%		1.722B
7.44%		2.011B
16.78%		2.389B
18.80%		1.131B
-52.66%		1.079B
-4.60%		1.044B
-3.24%		N/AN/A
EBIT
YoY % growth
UTHR ebit by date.UTHR ebit by date.
1.189B
19.94%		1.448B
21.84%		1.517B
4.77%		1.617B
6.58%		1.888B
16.76%		2.171B
14.99%		2.545B
17.23%		2.888B
13.48%		3.671B
27.11%		3.135B
-14.60%		3.243B
3.44%
Operating Margin
UTHR operating margin by date.UTHR operating margin by date.
51.06%50.33%47.67%47.76%48.84%48.52%50.21%51.05%56.43%45.78%44.71%
EPS
YoY % growth
UTHR eps by date.UTHR eps by date.
19.84
32.09%		24.60
23.99%		27.90
13.41%		29.23
4.76%		34.51
18.08%		39.66
14.92%		43.38
9.39%		46.95
8.22%		58.59
24.79%		53.93
-7.95%		55.28
2.51%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		6.96
5.05%		7.17
11.90%		7.25
1.22%		7.66
-0.56%		7.64
9.77%		7.72
7.58%		8.25
13.85%		9.37
22.36%
Revenue
Q2Q % growth		816.92M
2.83%		850.46M
6.49%		869.45M
8.75%		885.01M
12.00%		842.37M
3.12%		853.13M
0.31%		911.22M
4.80%		1.028B
16.16%
EBITDA
Q2Q % growth		427.37M
6.15%		449.67M
5.28%		464.98M
2.85%		452.49M
2.12%		N/AN/AN/AN/A
EBIT
Q2Q % growth		352.93M
-7.80%		366.07M
-5.21%		367.42M
-5.62%		379.52M
6.16%		441M
24.95%		446.56M
21.99%		480.88M
30.88%		549.58M
44.81%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

UTHR Yearly Revenue VS EstimatesUTHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
UTHR Yearly EPS VS EstimatesUTHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.44%
EPS Next 5 Year
10.97%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.06%
Revenue Next 5 Year
11.61%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
14.92%
EBIT Next 5 Year
-7.27%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

UNITED THERAPEUTICS CORP / UTHR Forecast FAQ

What is the price target for UTHR stock?

21 analysts have analysed UTHR and the average price target is 627.88 USD. This implies a price increase of 6.71% is expected in the next year compared to the current price of 588.38.

When does UNITED THERAPEUTICS CORP (UTHR) report earnings?

UNITED THERAPEUTICS CORP (UTHR) will report earnings on 2026-05-06, before the market open.

What are the consensus estimates for UNITED THERAPEUTICS CORP (UTHR) next earnings?

The consensus EPS estimate for the next earnings of UNITED THERAPEUTICS CORP (UTHR) is 6.96 USD and the consensus revenue estimate is 816.92M USD.

How many analysts have analysed UNITED THERAPEUTICS CORP (UTHR)?

The number of analysts covering UNITED THERAPEUTICS CORP (UTHR) is 21.